Hydrafacial Results Presentation Deck

Q1 2023 balance sheet highlights Cash and cash equivalents Warrants Convertible debt Revolving credit facility Shares outstanding 24 Approximately $532.3 million cash and cash equivalents on balance sheet Approximately 7 million Private Warrants outstanding $750 million 1.25% convertible notes due 2026 → Use of proceeds: capped call transaction, potential future acquisitions, working capital expenditures, and general corporate purposes → Conversion price of $31.76; capped call agreement provides dilution protection up to $47.94 $50 million Senior Secured Credit Facility remains undrawn; current undrawn commitment fee of 25 bps Allows flexibility for future M&A; ex-US operations unencumbered; convertible debt excluded from covenants Approximately 132.6 million current shares outstanding Both $100 million accelerated share repurchase programs completed; aggregate of 18.8 million shares retired at average price of $10.78 per share BEAUTYHEALTH™

View entire presentation